Physician profile
Amar Patel
NPI 1336726330
$11,005.21
in general payments reported to CMS, 2019-2025
14 companies · $3,966 in 2025
The $3,966 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,358 · 2023: $643 · 2024: $2,037 · 2025: $3,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,771 · Travel and Lodging: $685 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,771.33 |
| Travel and Lodging | $684.77 |
| Education | $190.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,072.39 | 2022-2025 | Mako, Pro, Hydroset |
| Pylant Medical | $3,894.34 | 2022-2025 | |
| Depuy Synthes Sales INC. | $477.66 | 2024-2025 | Na, Tfn-Advance, Fibergraft Aeridyan Matrix |
| Smith+Nephew, INC. | $384.32 | 2022 | |
| Davol INC. | $188.65 | 2024 | Arista Ah Flexitip |
| Kuros Biosciences USA, INC | $187.76 | 2025 | Magnetos |
| Bioventus LLC | $184.24 | 2025 | Exogen Ultrasound Bone Healing System |
| Cerapedics INC. | $168.02 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Pacira Pharmaceuticals Incorporated | $146.09 | 2025 | Iovera, Zilretta |
| Heron Therapeutics, INC. | $121.84 | 2025 | Zynrelef |
| Medical Device Business Services, INC. | $100.07 | 2024 | |
| Polynovo North America LLC | $36.95 | 2024 | Novosorb Btm |
| Ethicon US, LLC | $25.83 | 2024 | Surgicel Nu-Knit |
| P Bar Medical LLC | $17.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.